Literature DB >> 9197570

Perimetric probability maps to separate change caused by glaucoma from that caused by cataract.

B Bengtsson1, A Lindgren, A Heijl, G Lindgren, P Asman, M Patella.   

Abstract

We describe a new method for analysis of change in glaucomatous visual fields with the object to differentiate between changes caused by glaucoma from those caused by cataract. New pattern deviation change probability maps were developed from a prospectively collected glaucoma material and designed to be sensitive to changes in localized field loss, but to be unaffected by media-induced perimetric change. We compared the new change probability maps with the commercially available total deviation change probability maps in series of Humphrey perimetric tests in a glaucoma material of 43 eyes of 35 patients, who had undergone cataract surgery. When using the total deviation maps, considerable differences were seen between fields obtained before and after cataract surgery. Much smaller differences were seen when using the new change probability maps, that almost eliminated the common and disturbing effect of increasing cataract. This new tool could be of considerable help in differentiation between progressive glaucomatous visual field loss and deterioration caused by increasing media opacities.

Entities:  

Mesh:

Year:  1997        PMID: 9197570     DOI: 10.1111/j.1600-0420.1997.tb00121.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  22 in total

Review 1.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

2.  Progression detection in different stages of glaucoma: mean deviation versus visual field index.

Authors:  Jung Woo Cho; Kyung Rim Sung; Sung-Cheol Yun; Jung Hwa Na; Youngrok Lee; Michael S Kook
Journal:  Jpn J Ophthalmol       Date:  2011-12-28       Impact factor: 2.447

Review 3.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

4.  Some dissociating factors in the analysis of structural and functional progressive damage in open-angle glaucoma.

Authors:  C J W Hudson; L S Kim; S A Hancock; I A Cunliffe; J M Wild
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

5.  Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression.

Authors:  W L Membrey; C Bunce; D P Poinoosawmy; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

6.  Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.

Authors:  Angelo P Tanna; Donald L Budenz; Jagadeesh Bandi; William J Feuer; Robert M Feldman; Leon W Herndon; Douglas J Rhee; Julia Whiteside-de Vos; Joyce Huang; Douglas R Anderson
Journal:  Ophthalmology       Date:  2011-12-02       Impact factor: 12.079

7.  Performance of glaucoma progression analysis software in a glaucoma population.

Authors:  Francisco Arnalich-Montiel; Pilar Casas-Llera; Francisco J Muñoz-Negrete; Gema Rebolleda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-04       Impact factor: 3.117

8.  Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.

Authors:  M Roy Wilson
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 9.  [Frequency-doubling technology : A new method for determining glaucomatous visual field defects].

Authors:  J Lamparter; A Schulze; E M Hoffmann
Journal:  Ophthalmologe       Date:  2009-08       Impact factor: 1.059

10.  Structural and Functional Progression in the Early Manifest Glaucoma Trial.

Authors:  HannaMaria Öhnell; Anders Heijl; Lena Brenner; Harald Anderson; Boel Bengtsson
Journal:  Ophthalmology       Date:  2016-03-02       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.